Data as of Sep 30, 2026, 6:36 AM
Trades Jan 6, 2025 – Jul 17, 2026
Issuer
4 politicians disclosed trades in DXCM (DexCom, Inc.) between Jan 6, 2025 – Jul 17, 2026.
Trades
59
Politicians
4
Buy vol.
$1.1M
Sell vol.
$1.1M
Sector
A sale may close the position; filings are not a live holdings snapshot.
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Tina Smith | May 7, 2026 | 0 | 2 | $350.0k |
| John Boozman | Jan 26, 2026 | 1 | 0 | $8,001 |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Rob Bresnahan | May 15, 2025 | 2 | 1 | $24.0k |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Tina Smith | May 7, 2026 | 0 | 2 | $350.0k |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Donald J. Trump | Jul 17, 2026 | 35 | 18 | $1.8M |
| Rob Bresnahan | May 15, 2025 | 2 | 1 | $24.0k |
| John Boozman | Jan 26, 2026 | 1 | 0 | $8,001 |
| Politician | Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|---|
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | Jul 17, 2026 | $76.65 | $86.64 | Jul 17, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | Jun 15, 2026 | $74.22 | $86.64 | Jun 15, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | May 18, 2026 | $65.09 | $86.64 | May 18, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $100k–$250k | May 18, 2026 | $65.09 | $86.64 | May 18, 2026 | — |
| Tina Smith | DexCom, Inc.DXCM | Healthcare | Sale | $100k–$250k | May 7, 2026 | $60.91 | $86.64 | May 10, 2026 | 3 days |
| Tina Smith | DexCom, Inc.DXCM | Healthcare | Sale | $100k–$250k | Apr 29, 2026 | $57.56 | $86.64 | May 10, 2026 | 11 days |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $15k–$50k | Apr 27, 2026 | $61.41 | $86.64 | Apr 27, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $15k–$50k | Apr 27, 2026 | $61.41 | $86.64 | Apr 27, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $1k–$15k | Apr 17, 2026 | $63.98 | $86.64 | Apr 17, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $15k–$50k | Apr 10, 2026 | $64.02 | $86.64 | Apr 10, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $1k–$15k | Apr 7, 2026 | $63.11 | $86.64 | Apr 7, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $15k–$50k | Mar 25, 2026 | $66.84 | $86.64 | Mar 25, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $100k–$250k | Mar 17, 2026 | $67.32 | $86.64 | Mar 17, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | Feb 19, 2026 | $72.27 | $86.64 | Feb 19, 2026 | — |
| John Boozman | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | Jan 26, 2026 | $73.34 | $86.64 | Feb 15, 2026 | 20 days |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $100k–$250k | Feb 10, 2026 | $68.16 | $86.64 | Feb 10, 2026 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $1k–$15k | Dec 23, 2025 | $66.86 | $86.64 | Dec 23, 2025 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | Dec 11, 2025 | $68.94 | $86.64 | Dec 11, 2025 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Sale | $100k–$250k | Dec 4, 2025 | $65.25 | $86.64 | Dec 4, 2025 | — |
| Donald J. Trump | DexCom, Inc.DXCM | Healthcare | Purchase | $1k–$15k | Nov 21, 2025 | $60.23 | $86.64 | Nov 21, 2025 | — |
Download DXCM congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.
RSS for DXCMNew congressional filings in this symbol, by filing date.
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.